240
Participants
Start Date
October 29, 2020
Primary Completion Date
August 13, 2024
Study Completion Date
November 5, 2024
Flos gossypii flavonoids tablet
The distribution ratio between the groups was 1:1:1, and the stratification factor was the degree of illness CDR score. In the study, the entry of each subject into the high-dose group, low-dose group or placebo group will be determined by the randomized system.
Xuanwu Hospital of Capital Medical University, Beijing
Oriental Hospital of Beijing University of traditional Chinese Medicine, Beijing
PLA Northern Theater Air Force Hospital, Shenyang
Daqing People's Hospital, Daqing
Jiangsu Hospital of traditional Chinese Medicine, Nanyang
Wuxi Second People's Hospital, Wuxi
Yangzhou First People's Hospital, Yangzhou
Taizhou Hospital of traditional Chinese Medicine, Taizhou
Hefei Second People's Hospital, Hefei
Lu'an Hospital of traditional Chinese Medicine, Lu'an
The First Affiliated Hospital of Chongqing Medical University, Chongqing
Luoyang First Hospital of traditional Chinese Medicine, Luoyang
Sun Yat Sen Memorial Hospital of Sun Yat sen University, Guangzhou
Affiliated Hospital of Southwest Medical University, Luzhou
Shanxi Hospital of traditional Chinese Medicine, Xi’an
Xi'an High Tech Hospital, Xi’an
Xidian Group Hospital, Xi’an
Affiliated Hospital of Chengde Medical College, Chengde
The First Hospital of Shanxi Medical University, Taiyuan
Xinjiang Uygur Pharmaceutical Co., Ltd.
INDUSTRY
Capital Medical University
OTHER